This inventor holds 2 USPTO granted patents. Top assignee: Ludwig Heumann & Co. Gmbh. Active years: 1978-1979.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Roethenbach, DE (1978)
- Rothenbach, DE (1979)
Company Filing History:
Years Active: 1978-1979
Title: Edgar Fritschi: Innovator in Pharmaceutical Compounds
Introduction
Edgar Fritschi is a notable inventor based in Roethenbach, Germany, with a focus on developing innovative pharmaceutical compounds. He holds two patents that contribute significantly to the field of medicine, particularly in enhancing antibacterial properties and providing antispasmodic effects.
Latest Patents
Fritschi's latest patents include:
1. **2,4-Diamino-5-(4'-methylthio)benzylpyrimidenes** - This invention involves a compound that is a 2,4-diamino-5-thiobenzylpyrimidine, represented by the formula where R can be hydrogen, alkyl, lower alkoxy, or halogen, and R' is alkyl. These compounds exhibit antibacterial action and serve as sulphonamide potentiators, which enhance the effects of other antibacterial agents.
2. **Antispasmodic Substituted Sulphoximides** - This invention provides compounds based on a general formula, where R¹ and R² can independently represent various group types including straight chain alkyl, branched chain alkyl, and aryl groups, among others. These compounds are designed to have therapeutic applications in treating conditions requiring spasm relief.
Career Highlights
Fritschi has made substantial contributions to pharmaceutical innovations while working at Ludwig Heumann & Co. GmbH. His work focuses on identifying and developing compounds that hold potential for significant medical applications, particularly in antibacterial therapies and spasm relief treatments.
Collaborations
Throughout his career, Fritschi has collaborated with esteemed colleagues such as Walter Otto Liebenow and Jaroslav Prikryl. These partnerships further enhance the creative and research-driven environment that fosters innovation at Ludwig Heumann & Co. GmbH.
Conclusion
Edgar Fritschi's contributions to the field of pharmaceutical compounds through his innovative patents exemplify the importance of research and development in medicine. With a commitment to improving health outcomes, his work continues to inspire future innovations within the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile